Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Total Non-Current Liabilities: 2016-2025

Historic Total Non-Current Liabilities for cbdMD (YCBD) over the last 7 years, with Jun 2025 value amounting to $201,235.

  • cbdMD's Total Non-Current Liabilities fell 93.20% to $201,235 in Q2 2025 from the same period last year, while for Jun 2025 it was $201,235, marking a year-over-year decrease of 93.20%. This contributed to the annual value of $2.5 million for FY2023, which is 38.91% down from last year.
  • As of Q2 2025, cbdMD's Total Non-Current Liabilities stood at $201,235, which was down 49.71% from $400,144 recorded in Q1 2025.
  • In the past 5 years, cbdMD's Total Non-Current Liabilities registered a high of $28.3 million during Q1 2021, and its lowest value of $201,235 during Q2 2025.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $2.5 million (2023), whereas its average is $2.1 million.
  • Per our database at Business Quant, cbdMD's Total Non-Current Liabilities surged by 93.46% in 2021 and then tumbled by 93.20% in 2025.
  • Over the past 5 years, cbdMD's Total Non-Current Liabilities (Quarterly) stood at $8.2 million in 2021, then tumbled by 56.11% to $3.6 million in 2022, then crashed by 41.77% to $2.1 million in 2023, then tumbled by 71.65% to $591,583 in 2024, then crashed by 93.20% to $201,235 in 2025.
  • Its Total Non-Current Liabilities stands at $201,235 for Q2 2025, versus $400,144 for Q1 2025 and $591,583 for Q4 2024.